Drug misuse and dependency

Services

Drugs Test 1 (DT1) form

Form for the testing of specified class A drugs on persons ages 18 or over.

Controlled drugs list
- Guidance
- 1 April 2025
- Home Office
Supplying take home naloxone without a prescription
- Detailed guide
- 23 April 2025
- Department of Health and Social Care
Drug misuse and dependence: UK guidelines on clinical management
- Guidance
- 15 December 2017
- Department of Health and Social Care
ASSIST-Lite screening tool: how to use
- Guidance
- 7 April 2021
- Closed organisation: Public Health England
Drug and alcohol treatment and recovery funding: 2025 to 2026
- Guidance
- 1 May 2025
- Department of Health and Social Care

Resistance emerges to newest antibiotic
- 29 April 2025
- UK Health Security Agency
- News story
ACMD work programme 2025
- 12 March 2025
- Advisory Council on the Misuse of Drugs
- Correspondence
Government response to ACMD advice on reform to hemp licensing fees
- 11 February 2025
- Home Office
- Correspondence
ACMD appoints new members
- 10 February 2025
- Advisory Council on the Misuse of Drugs
- News story
Updated harms assessment of ketamine: commissioning letter
- 16 January 2025
- Advisory Council on the Misuse of Drugs
- Correspondence

Local preparedness for synthetic opioids in England
- 9 May 2025
- Home Office
- Research
Substance misuse treatment in secure settings: 2023 to 2024
- 30 January 2025
- Office for Health Improvement and Disparities
- Official statistics
Drug misuse in England and Wales: year ending March 2024
- 12 December 2024
- Office for National Statistics
- Official statistics
IPS for alcohol and drug dependence: data linkage outcomes
- 11 December 2024
- Office for Health Improvement and Disparities
- Research
People who inject drugs: HIV and viral hepatitis monitoring
- 11 December 2024
- UK Health Security Agency
- Research

Proposals to expand access to take-home naloxone supplies
- 14 May 2024
- Department of Health and Social Care, Department of Health (Northern Ireland), The Scottish Government, and Welsh Government
- Consultation outcome
- Date closed 06 March 2024
Expanding access to naloxone
- 24 January 2024
- Department of Health and Social Care
- Consultation outcome
- Date closed 28 September 2021
Drug prevention policies and landscape across the UK
- 5 January 2024
- Home Office and Advisory Council on the Misuse of Drugs
- Closed call for evidence
ACMD internet-facilitated drug markets review
- 20 December 2023
- Home Office and Advisory Council on the Misuse of Drugs
- Closed call for evidence
Drug use in ethnic minority groups
- 21 September 2023
- Home Office and Advisory Council on the Misuse of Drugs
- Closed call for evidence

Drug Testing on Arrest (DToA): programme data
- 12 February 2025
- Home Office
- Transparency
Advisory Council on the Misuse of Drugs member biographies
- 10 February 2025
- Advisory Council on the Misuse of Drugs
- Transparency
Standard Operating Procedure for using evidence in ACMD reports
- 3 January 2025
- Advisory Council on the Misuse of Drugs
- Corporate report
ACMD annual report 2020 to 2022
- 20 December 2024
- Advisory Council on the Misuse of Drugs
- Corporate report
From harm to hope: first annual report 2022 to 2023
- 27 February 2024
- Home Office
- Corporate report